The findings that the PML-RARA transduced-CD34+ cells developed APL while the resultant CD34− APL cells exhibited transplantability indicate the possibility that the initiation and maintenance of APL arise at different steps of differentiation, which are not likely to involve the CD34+/CD38− fraction, as originally reported in human AML. The gene discussed is CD38; the disease is acute promyelocytic leukemia.